goitre who present local compression symptoms.
|
|
- Amy Robertson
- 5 years ago
- Views:
Transcription
1 Radiidine therapy in vluminus multindular nn-txic gitre Jean Vereist, Marc Bnnyns, and Daniel Gliner Departments f Internal Medicine and Radiistpes, University Hspital Saint-Pierre, Brussels, Belgium Abstract. Large dses f radiidine were administered since 1969 t 15 euthyrid patients with cmpressive vluminus gitres. A decrease in gitre size was bserved in all patients (between 15 and 63%, average 39%). Maximal effect n gitre size was attained rapidly, partially already after less than ne year and was almst maximal after 24 t 30 mnths. N significant lcal adverse reactins were bserved; n patient required sterid administratin. Hypthyridism fllwed radiidine administratin in 30% f the patients after 2 years; after 8 years, all thse wh had survived were hypthyrid, requiring substitutin therapy. In all patients there was a marked imprvement in cmpressin symptms. The use f radiactive idine therapy cnstitutes an alternative t surgery in selected patients with large cmpressive gitres in whm surgery is cntraindicated because f age r ther medical cnditins. Preliminary results f the present studies were presented at the Annual Meeting f the Eurpean Assciatin f Nuclear Medicine, Milan, 1988, and at the 17th Annual Meeting f the Eurpean Thyrid Assciatin, La Grande Mtte-Mntpellier, September The therapeutic administratin f radiidine has nw gained large acceptance thrughut the wrld fr the management f hyperthyridism (1-3). In this clinical cnditin, it is assumed that radiidine induces radiatin damage t the thyrid fllicular cells, leading t impaired replicatin and eventu ally t reductin in the size f the thyrid (4). Rad iidine therapy is, hwever, als emplyed in ther clinical cnditins, such as treatment f mé tastases frm thyrid differentiated cancer and ab latin f cervical remnants after incmplete surgery fr thyrid cancer. It is therefre apparent that thyrid tissue mass can be reduced by admin istratin f radiidine. Hence, this tl may be applicable t euthyrid patients with multindular gitre wh present lcal cmpressin symptms. In the present article we reprt n the retrspec tive results f radiidine administratin ver a perid f 20 years in a grup f inperable euthy rid patients with vluminus multindular gitre. These elderly patients were cnsidered inperable fr reasns related t their age and/r assciated medical disease, r because they refused surgery (and in sme cases because surgens refused t p erate n them). The patients required therapy be cause f recent increase in gitre size, respiratry distress symptms due t trachéal cmpressin, and in rare instances because f discmfrt related t dysphagia. Patients and Methds A grup f 15 patients (11 females and 4 males), aged 62 t 86 years, were treated since It is ntewrthy that 9 f 15 patients (mean age 67 years) were treated between 1969 and 1978, but nly 6 patients (mean age 76 years) after The higher mean age f patients during the latter decade indicates that during recent years lder pa tients were mre frequently referred t surgery. All pa tients had a multindular gitre, in mst instances asym metrical and with variable degrees f substernal exten sin. Gitre had been present since many years (sme times decades) and was mst frequently stable in size. In sme patients hrmne substitutin therapy had been given previusly fr lng perids f time, mst generally
2 withut reductin f gitre size. All patients had always been cnsidered as clinically euthyrid and were cn firmed t be bth clinically and bichemically euthyrid after the initial evaluatin in ur institutin. X-rays ex aminatin revealed trachéal deviatin in all cases and tra chea! cmpressin in 60% f them. g S ï 10 <TSH) X <UT=9» V Results Thyrid scintiscan with 131I ( MBq) was perfrmed befre treatment, and shwed hetergenus tracer distributin. The thyridal 24-h uptake ranged frm 9 t 69% (mean ± sem 43±5). The mean value f prtein-bund 131I, measured 24-h after tracer administratin, was within the ref erence range f ur nrmal ppulatin, i.e. belw 0.10% dse/1. The thyrid size was estimated frm scintigraphy by planimetry, fllwing the methd f Mandart & Erbsmann (5). Glandular size ranged > J Befre RI Alter RI Cmparisn f thyrid vlumes befre and after radii dine (Ri) therapy in 15 patients. Mean±sEM are repre sented by the symbl Thyrid vlume was estimated by planimetry frm scintigraphy f the gland carried ut 24 h after the administratin f 50 r 100 nci 131I ( MBq) HO Mnths After Radiidine 2. Changes in thyrid vlume after radiidine administra tin, expressed as percent f the initial glandular vlume. In sme cases, mre than ne scintigraphy was btained during the fllw-up. Only the data frm the first scin tigraphy btained (with the shrtest delay) after radii dine administratin is illustrated in the figure and was taken int accunt t calculate the reductin in size. O see text. between 106 and 252 g, with a mean (±sem) f 175±13g. The therapeutic radiidine dse administered was calculated taking int accunt the determina tin f thyridal uptake in the preliminary tracer study in rder t deliver 75 t 100 pci (2.8 t 3.7 MBqVgram tissue. Dses given varied between 740 and 1850 MBq, with a mean (±sem) f 1184± cmpares the thyrid vlume befre rad iidine therapy t the vlume estimated frm a scintigraphy btained at varius intervals during the fllw-up perid in each patient. A reductin in size was evident in every patient treated, in the very large (abve 200 g) as well as in the less vluminus glands. Individual changes in vlume were rughly parallel and the mean decrease fr the grup was 39%, frm 175 t 110 g. 2. illustrates the decrease in thyrid size, as a percent f the initial vlume, during the fllwup f patients. The figure cmpares thyrid scin tigraphy in the 15 patients, perfrmed at different time intervals after radiidine administratin, be tween 0.5 and 13 years (median 2). Reductin in the vlume f gitre was rapid, already evident after less than ne year in 3 patients (in whm it was assessed at this early stage). Maximal effect was b tained after mnths; thereafter, changes in size were nly minr. Tw patients were f special interest (indicated by O in the figure 2). In ne, the
3 3. Typical example f thyrid scintigraphy befre radiidine administratin (left panel) and at different time intervals after radiidine administratin (right panels). effect f radiidine n vlume reductin was small, reaching nly 17% f the initial vlume after 5 years. In this patient, radiidine had been given despite a lw 24-h uptake (9%) and the treatment bviusly did nt cmpletely fulfil its jb. In the secnd patient, a marked and rapid vlume reduc tin was bserved, reaching 63% after 1 year. This patient had been given radiidine after thyrid stimulatin with bvine TSH, thereby explaining the "super" effect. Fr radiprtectin reasns and 4. See legend t allw fr a careful bservatin, all patients were taken int the hspital during 3-7 days after rad iidine. Thereafter patients were discharged and examined regularly n an utpatient basis during the first 6 weeks. Fllwing treatment, there was n single instance f acute increase in gitre size, nr acute exacerbatin f bstructive symptms, nr episdes f thyrid dysfunctin. N patient re quired sterid administratin. During the lngterm fllw-up, hypthyridism develped in 30% t 3.
4 f the patients after 2 years. After 8 years all thse wh survived had becme hypthyrid, requiring hrmne substitutin therapy. Figs. 3 and 4 illustrate the thyrid scintigraphic changes in tw typical patients befre and after radiidine therapy shwing the reductin in glan dular size with time. Discussin Nn-txic multindular gitre is a relatively cmmn cnditin. The natural histry f such gitres is usually that f a slw and prgressive grwth with frequent increase in number and size f ndules. Spntaneus reductin in size is ex ceedingly rare. Furthermre, when thyrid hr mne substitutin is administered with the aim t reduce r stabilize the size f lng-standing gitre, it remains frequently ineffective. Radical therapy, if required fr csmetic reasns r lcal cmpres sin symptms, generally cnsists in surgical re mval, especially in yunger patients. In 10 t 15% f perated patients, hwever, recurrence f gitre has been reprted (6). The grup f patients reprted herein cmprises 15 elderly patients with lng-standing nn-txic multindular gitre, wh fr varius reasns culd nt be submitted t surgery. The patients required therapy because f recent increase in gitre size, symptms related t trachéal cmpressin r dysphagia. The pssible ccurrence f thyrid cancer was assessed using the available clinical criteria and in a few recent patients by benign cytlgy btained frm fine-needle aspiratin. In the absence f sur gical data, cancer culd nt strictly be ruled ut, but it was never disclsed in any f the patients during the fllw-up perid and was therefre unlikely. The patients were treated with a single administra tin f a relatively large dse f radiidine ( 1184 MBq n the average). The results indicate that a significant reductin in gitre vlume was btained in all patients, averaging 40%. Radilgical cm pressin f the trachea shwed an imprvement in all patients. Similarly, the subjective symptms im prved in all patients. There was n serius adverse reactins and sterid administratin was nt nec essary. Fr cmparisn, we als analysed retrspectively the changes in thyrid vlume resulting frm rad iidine administratin in 22 thyrtxic patients with gitres greater than 100 grams (results nt shwn). Decrease f thyrid vlume with time was similar t that f ur patients with nn-txic gi tres, indicating that there was n»radiresistance«in the latter patients. Recently, tw reprts have been published deal ing with the same questin in different grups f patients. Kay et al. (6) shwed similar results in patients previusly perated fr gitre and with subsequent recurrence. One difference between the results f Kay et al. and urs is that, while hypthyridism ccurred infrequently in their pa tients (presumably because they were yunger than urs), hypthyridism was frequent in ur series. Hence, careful fllw-up f elderly patients is man datry and thyrid hrmne substitutin shuld be initiated when required. In the article f Hegedüs et al. (7), the patients had smaller gitres and were fllwed during nly the first 12 mnths after rad iidine administratin. The authrs als bserved changes in thyrid vlume, ccurring already during the first year, with n adverse reactins frm therapy. In cnclusin, surgical remval is the treatment f chice fr multindular gitre. Hwever, the use f radiactive idine cnstitutes a valuable alterna tive in selected patients with large nn-txic mul tindular gitres, in particular in thse wh, be cause f age r ther medical cnditins, are un suitable fr surgery. Acknwledgments The authrs wish t thank Prf A. M. Ermans fr his cnstant supprt and interest in their wrk. The authrs gratefully acknwledge Mrs Brigitte De Brauwer fr expert secretarial help. References 1. Beierwaltes WH. The treatment f hyperthyridism with idine-131. Semin Nucl Med 1978;8: Henneman G, Krenning EP, Sankaranarayanan K. Place f radiactive idine in treatment f thyrtxicsis. Lancet 1986;1: OrgiazziJ. Management f Graves'hyperthyridism. Endcrinl Metab Clin Nrth Am. 1987;16: Gldsmith RE. Radiistpe therapy fr Graves' dis ease. May Clin Prc 1972;47: Mandan G, Erbsmann F. Estimatin f thyrid
5 weight by scintigraphy. Intern J Nucl Med Bil 1975;2: Kay TWH, d'emden MC, Andrews JT, Martin FIR. Treatment f nn-txic multindular gitre with ra diactive idine. Am J Med 1987;84: Hegediis L, Hansen BM, Knudsen N, Hansen JM. Reductin f size f thyrid with radiactive idine in multindular nn-txic gitre. Br Med J 1987; 297: Received September 8th, Accepted January 8th, Dr D. Gliner, Hôpital Saint-Pierre, Université Libre de Bruxelles, Department f Internal Medicine, 322, rue Haute, B-1000 Bruxelles, Belgium.
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationNeurological outcome from conservative or surgical treatment of cervical spinal cord injured patients
1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationACRIN 6666 Screening Breast US Follow-up Assessment Form
Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related
More informationField Epidemiology Training Program
Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationBasic Thyroid Examination
Basic Thyrid Examinatin WIPE Wash hands Intrduce yurself Permissin Psitin (Patient sat in frnt f yu upright) Expsure (Neck expsed) Identify Patient (cnfirm the fllwing details befre starting) Name Age
More informationThe demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY
205 The demnstratin f lyssmes by the cntrlled temperature freezing-sectining methd By LUCILLE BITESKY (Frm the Department f Pathlgy, Ryal Cllege f Surgens f England, Lincln's Inn Fields, Lndn, W.C. 2)
More informationCONGENITAL NASOLACRIMAL DUCT OBSTRUCTION IN THE SECOND YEAR OF LIFE: A MULTI CENTRE TRIAL OF MANAGEMENT
CONGENITAL NASOLACRIMAL DUCT OBSTRUCTION IN THE SECOND YEAR OF LIFE: A MULTI CENTRE TRIAL OF MANAGEMENT J. D. H. YOUNG\ c. J. MacEWEN! and S. A. OGSTON Dundee Cllabrating surgens: G. J. Bedfrd, Dumfries;
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More informationDRAFT Policy for the Management of Ear Wax
Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1
More informationM.R.C.Path. causes to the raised plasma urea in patients admitted
Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,
More informationCnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level
More informationTHROUGH 1979, immunosuppressive
Five-Year Survival After Liver Transplantatin THROUGH 1979, immunsuppressive therapy fr liver transplantatin at ur center was with aathiprine (r cyclphsphamide) and sterids, t which antilymphcyte glublin
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationTREATMENT OF POLYCYTHEMIA VERA
RUSSELL L. HADEN, M.D. Plycythemia vera is characterized by an increase in the number f red bld cells. This disease is insidius in rigin, chrnic, and withut pathgnmnic symptms r physical findings. Early
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationContinuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP
Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationWeight gain and height velocity during prolonged first remission from acute lymphoblastic. years and 15 for two years. Three patients who
Archives f Disease in Childhd, 1985, 60, 832-836 Weight gain and height velcity during prlnged first remissin frm acute lymphblastic leukaemia C P Q SAINSBURY, R G NEWCOMBE, AND I A HUGHES Departments
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationSterilization. B.K. Merritt, MD. Second most common form of birth control after pills. Surgical (tubal ligation or removal)
Sterilizatin B.K. Merritt, MD Overview Secnd mst cmmn frm f birth cntrl after pills Shuld never be cnsidered reversible Mirena IUD and Nexplann implant are bth reversible and are as effective r even mre
More informationHow to become an AME Online
Hw t becme an AME Online 1. Check that yu meet the minimum technical requirements in rder t use the AME Online system: Operating System: Windws Vista (Service Pack 2) Windws 7 Windws 8, 8.1 Windws 10 Please
More informationTriumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media
Triumeq (abacavir, dlutegravir and lamivudine) Prduct Backgrunder fr US Media What is Triumeq and wh is Triumeq fr? Triumeq (abacavir 600mg, dlutegravir 50mg and lamivudine 300mg) is the first dlutegravir-based
More informationScreening Questions to Ask Patients
Screening Questins t Ask Patients 1. Have yu ever had TB (Tuberculsis)? Yes N 2. Have yu been living with anyne in the past tw years that has been diagnsed with TB? Yes N 3. Have yu ever had a Persistent
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationCONTENTS Beyond Five
CONTENTS What is thyrid?... 2 What des the thyrid d?... 3 What is thyrid cancer?... 3 What causes thyrid cancer?... 4 What are the signs and symptms f thyrid cancer?... 5 Hw is thyrid cancer diagnsed?...
More informationOriginal Policy Date
MP 5.01.27 Thyrgen (Thyrtrpin Alfa) Medical Plicy Sectin Prescriptin Drug Issue 12:2013 Original Plicy Date 12:2013 Last Review Status/Date Created with literature search/12:2013 Return t Medical Plicy
More informationSERIAL ASSAYS OF PLASMA GROWTH HORMONE IN TREATED AND UNTREATED ACROMEGALY*
SERIAL ASSAYS OF PLASMA GROWTH HORMONE IN TREATED AND UNTREATED ACROMEGALY* W. M. HUNTER, F. J. GILLINGHAM, P. HARRIS, J. A. KANIS, F. M. McGURK, J. McLELLAND AND J. A. STRONG Medical Research Cuncil Radiimmunassay
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationDEMENTIA. DESCRIPTION: a progressive, degenerative disease of the brain, which causes impairment of thinking and memory
DEMENTIA Dementia a syndrme cnsisting f a number f symptms including lss f memry, judgment and reasning, and changes in md and behavir the changes may affect a persn's ability t functin at wrk, in scial
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationMETHYL TESTOSTERONE IN PREMATURE INFANTS
METHYL TESTOSTERONE IN PREMATURE INFANTS BY URSULA JAMES and B. L. COLES Frm the General Lying-In and Annie McCall Hspitals, Lndn (RECE:IVED FOR PUBLICATiN crber 18. 195 1) It is an established fact that
More informationpotassium status of patients with heart failure
Pstgraduate Medical Jurnal (June 1978) 54, 45-49. The effects f ptassium supplements, spirnlactne r amilride n the ptassium status f patients with heart failure C. DAVIDSON M.A., M.B., M.R.C.P. D. B. MORGAN
More informationdetailed in Ward and Lockhead (1970), is only summarized here.
Respnse system prcesses in abslute judgment* LAWRENCE M. WARDt and G. R. LOCKHEAD Duke University, Durham, Nrth Carlina 2778 Cnsistent relatinships are fund between Ss' abslute judgments f the value f
More informationNHAIS SIS Communication
T: All NHAIS Key Users/Screening Managers Frm: Catherine Rberts SIS Request: T/14528 HSCIC Change Number: 15846 Date: 24/03/2015 Page 1 f 5 Impacted Applicatins: SD screen, Lab Links, MM screen, AJ-CD
More informationFOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES
Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationThyroglobulin levels in serum and saliva of patients with differentiated thyroid carcinoma
Pre, Indian Acad. Sci., Vl. 87 B (Experimental Bilgy-J), N.7, July 1978. pp. 169-1". @ printed in India Thyrglbulin levels in serum and saliva f patients with differentiated thyrid carcinma D SHAH, S DANDEKAR
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationBefore Your Visit: Mohs Skin Cancer Surgery
Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with
More informationCSE 331, Spring 2000
YOUR NAME: SECTION NUMBER: CSE 331, Spring 2000 Class Exercise 15 Algrithm Design Techniques-Greedy Algrithms March 13, 2000 Fllwing are five f the cmmn types f algrithms. Fr many prblems it is quite likely
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationClinical Study Synopsis
Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice
More informationFrequently asked questions: Influenza A (H1N1)v
July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationA. Catalonia World Health Organization Demonstration Project
A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationA fake medicine that passes itself off as a real, authorised medicine. (1)
Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationDental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.
Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,
More informationRefining Blood Collection Techniques to Improve Animal Welfare and Sample Quality
Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationTopic 12: Endocrine System. Function: Group of glands that produces regulatory chemicals ( )
Tpic 12: Endcrine System Functin: Grup f glands that prduces regulatry chemicals ( ) Hrmnes: Chemical messengers released directly int the bldstream that regulate: *May have wide-spread effects r nly affect
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationNFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health
NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More information2. How are screening and diagnostic mammograms different?
Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More informationSTUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM
Published Online: 1 June, 1936 Supp Inf: http://di.rg/1.184/jem.63.6.83 Dwnladed frm jem.rupress.rg n August 13, 218 STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM BY T. P. MAGILL,
More informationInterpretation. Historical enquiry religious diversity
Name: Year 8 Histry Prject 3: D The Cmmnwealth Games Still Matter In The 21 st Century? Mdule: Date Set: Deadline: Descriptin f the task: The prject is split int three separate parts: The prject is split
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationALLERGY. The effect of alternate-day prednisone on the white blood count in children with chronic asthma
The Jurnal f ALLERGY and CLINICAL IMMUNOLOGY VOLUME 51 NUMBER 2 The effect f alternate-day prednisne n the white bld cunt in children with chrnic asthma H. Cha, M.D., and A. Gilbert, M.T. Denver, Cl. Children
More informationPROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon
PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided
More informationCDC Influenza Division Key Points November 7, 2014
In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates
More information2018 Medical Association Poster Symposium Guidelines
2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the
More informationMale patients with pain, swelling or erythema please refer to the Acute Painful Scrotum pathway Female patients
UNDESCENDED TESTICLE ALGORITHM Unilateral undescended testicle OR Bilateral palpable undescended testicle Inclusin Criteria: Male patients w/ unilateral r bilateral undescended testicle(s) Exclusin Criteria:
More informationA foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:
RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More information